Jay Duker, MD, discusses EYP-1901, EyePoint Pharmaceuticals’ sustained-release anti-VEGF drug for the treatment of wet AMD.
Expert Interviews
Advertisement
At AAO 2021, Aerie Pharmaceuticals presented the results of their phase 2b clinical trial of AR-15512, a triple 8 antagonist, for the treatment of dry eye.
Advertisement
Mohamed Abou Shousha, MD, PhD, discusses Heru’s wearable AI-powered diagnostic devices at AAO 2021.
Verana Health showcases the VeraQ quality measures dashboard for the IRIS registry report at AAO 2021.
Retinopathy of prematurity expert C. Armitage Harper, III, MD, of the Austin Retina Associates in Austin, Texas, discusses his experience in treating ROP cases across the globe, and his mission to prevent pre-term blindness in infants.
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
Retinal imaging as a window into atrial fibrillation
2
Comments from the FDA Advisory Committee meeting on SYD-101
3
Lambert-Eaton Myasthenic Syndrome: how eye care professionals differentiate it from myasthenia gravis
4
OT Roundup: 3 FDA approvals, vorolanib insert miss, brepocitinib in uveitis
5